As assessed by ICC and IHC, primary CML cells expressed substantial amounts of BRD4 and MYC in most patients examined without major differences in staining intensity when comparing CP and BP samples (Figure 1A,B). This evidence concerns the gene BRD4 and intrahepatic cholangiocarcinoma.